PD-1 aborts the activation trajectory of autoreactive CD8+ T cells to prohibit their acquisition of effector functions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD-1 aborts the activation trajectory of autoreactive CD8+ T cells to prohibit their acquisition of effector functions

Published:2019-12 Issue: Volume:105 Page:102296
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Okamura Hikari,Okazaki Il-mi,Shimizu Kenji,Maruhashi Takumi,Sugiura Daisuke,Mizuno Reina,Okazaki Taku

Funder

Japan Society for the Promotion of Science

Japan Science and Technology Agency

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference50 articles.

1. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates;Brahmer;J. Clin. Oncol.,2010

2. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade;Iwai;Proc. Natl. Acad. Sci. U. S. A.,2002

3. A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application;Okazaki;Nat. Immunol.,2013

4. Cancer immunotherapy using checkpoint blockade;Ribas;Science,2018

5. Coinhibitory pathways in the B7-CD28 ligand-receptor family;Schildberg;Immunity,2016

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elucidating molecular and cellular mechanisms of singularity phenomena in immunology;Biophysics and Physicobiology;2024

2. Type 1 diabetes mellitus induced by PD-1 inhibitors in China: a report of two cases;Journal of International Medical Research;2022-09

3. Temporal profiling of CD4 T-cell activation and differentiation upon SARS-CoV-2 spike protein immunisation;2022-07-21

4. Single-cell level temporal profiling of tumour-reactive T cells under immune checkpoint blockade;2022-07-20

5. Anti-nuclear antibody and a granuloma could be biomarkers for iCIs-related hepatitis by anti-PD-1 treatment;Scientific Reports;2022-03-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3